ストックスクリーナーアプリを入手
2.56
0.39%
-0.010
アフターアワーズ：
2.56
前日終値:
$2.57
開ける：
$2.62
24時間の取引高:
195.88K
Relative Volume:
0.04
時価総額：
$44.21M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-2.29%
1か月 パフォーマンス:
+1.99%
6か月 パフォーマンス:
-36.79%
1年 パフォーマンス:
-23.35%
1日の値動き範囲:
$2.54
$2.625
1週間の範囲:
$2.54
$2.6891
52週間の値動き範囲:
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
MURA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
2.56 | 45.59M | 0 | 0 | 0 | 0.00 |
|
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.69B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 114.81B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.232 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
84.34 | 6.60B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 65.36B | 14.09B | 4.50B | 2.96B | 39.28 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-25 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | 開始されました | Rodman & Renshaw | Buy |
| 2024-04-04 | 開始されました | Morgan Stanley | Overweight |
Mural Oncology Plc (MURA) 最新ニュース
BlackRock discloses stake in Mural Oncology - Investing.com India
Form 8.3Mural Oncology plc - Business Wire
BlackRock Reveals 1.58% Holding in Mural Oncology - Insider Monkey
BlackRock reports 1.58% stake in Mural Oncology By Investing.com - Investing.com South Africa
BlackRock reports 1.58% stake in Mural Oncology - Investing.com
Mural Oncology plc (NASDAQ:MURA) Holdings Lifted by Northern Trust Corp - Defense World
BlackRock discloses stake in Mural Oncology By Investing.com - Investing.com South Africa
Goldman Sachs adjusts positions in Mural Oncology By Investing.com - Investing.com South Africa
Goldman Sachs adjusts positions in Mural Oncology - Investing.com Australia
Mural Oncology Announces Number of Relevant Securities in Issue - The Manila Times
Goldman Sachs reports trading in Mural Oncology shares By Investing.com - Investing.com South Africa
Mural Oncology Discloses Share Count Under Irish Takeover Rules: What's Behind This Move? - Stock Titan
Goldman Sachs reports trading in Mural Oncology shares - Investing.com Australia
Mural Oncology plc (NASDAQ:MURA) Shares Sold by Price T Rowe Associates Inc. MD - Defense World
Goldman Sachs reveals stake in biopharmaceutical firm Mural Oncology - Dimsum Daily
Goldman Sachs discloses stake in Mural Oncology By Investing.com - Investing.com South Africa
Goldman Sachs discloses stake in biopharmaceutical firm Mural Oncology - Dimsum Daily
Goldman Sachs discloses stake in Mural Oncology - Investing.com
Goldman Sachs reports dealings in Mural Oncology shares By Investing.com - Investing.com Nigeria
Goldman Sachs reports dealings in Mural Oncology shares - Investing.com
BlackRock discloses stake in Mural Oncology plc By Investing.com - Investing.com South Africa
BlackRock discloses stake in Mural Oncology plc - Investing.com
BlackRock reports stake in Mural Oncology By Investing.com - Investing.com Canada
Mural Oncology Plc (MURA) 財務データ
Mural Oncology Plc (MURA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Mural Oncology Plc (MURA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Keson-Brookes Maiken | See Remarks |
Mar 05 '25 |
Sale |
3.45 |
1,469 |
5,068 |
73,564 |
| Keson-Brookes Maiken | See Remarks |
Mar 04 '25 |
Sale |
3.36 |
1,262 |
4,240 |
75,033 |
| Loew Caroline | Chief Executive Officer |
Mar 04 '25 |
Sale |
3.36 |
4,313 |
14,492 |
305,590 |
0.00%
2.33%
大文字化:
|
ボリューム (24 時間):